Prolongation of pregnancy in patients suffering from HELLP syndrome;Schwangerschaftsverlagerung bei patientinnen mit HELLP-syndrom

Geburtshilfe und Frauenheilkunde

Volumn 59, Issue 7, 1999, Pages 335-345

  Fischer, Thorsten ^a   Krause, M ^b   Beinder, E ^b   Schlembach, D ^b   Rabenbauer, B ^b   Wildt, L ^b   Lang, N ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ATENOLOL; DIAZEPAM; DIHYDRALAZINE; HAPTOGLOBIN; HYDRALAZINE; KETANSERIN; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; METHYLDOPA; METHYLPREDNISOLONE; PROSTAGLANDIN E2;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; HELLP SYNDROME; HEMOLYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LACTATE DEHYDROGENASE BLOOD LEVEL; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; THIRD TRIMESTER PREGNANCY; THROMBOCYTE COUNT;

EID: 0032789453     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-15371     Document Type: Article

References (47)

1. Aarnoudse, J. G., H. J. Houthoff, J. Weits, E. Vellenga, H. J. Huisjes: A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy: A clinical and histopathological study. Brit. J. Obstet. Gynecol. 92 (1986) 145-155.
2. Boy, K., U. Zimmermann, L. Wildt: Enhanced tumor necrosis factor alpha (TNF alpha) secretion by stimulated mononuclear leucocytes in gestosis. Exper. Clin. Endocrinol. Diabetes 103 (Suppl. 1) (1995) 42 (abstract).
3. Clark, S. L., J. R. Phelan, S. H. Allen, S. R. Golde: Antepartum reversal of hematologic abnormalities associated with the HELLP-syndrome. J. Reprod. Med. 31 (1986) 70-72.
4. Dupont, E., J. Wybran, C. Toussaint: Glucocorticosteroids and organ transplantation. Transplantation 37 (1984) 331-335.
5. Eeltink, C. M., R. A. van Lingen, J. G. Aarnoudse, J. B. Derks, A. Okken: Maternal haemolysis, elevated liver enzymes and low platelets syndrome: specific problems in the newborn. Europ. J. Pediat. 152 (1993) 160-163.
6. Gortner, L., F. Pohlandt, P. Bartmann, R. Terrinde, H. Versmold, O. Dorigo: Short term outcome in infants with birth weight < 1750 g born to mothers with HELLP syndrome. J. Perinat. Med. 20 (1992) 25-28.
7. Geary, M.: The HELLP-Syndrome. Brit. J. Obstet. Gynaecol. 104 (1997) 887-891.
8. Grillo, M., G. Bonig, D. Weisner: HELLP-Syndrom in der 23. SSW. Ein Fallbericht mit Literaturübersicht. Zbl. Gynäkol. 112 (1990) 39-43.
9. Hamm, W., G. Richardsen, A. Bolte: Die Bedeutung der frühzeitigen Diagnose und unverzüglichen Entbindung bei Patientinnen mit HELLP-Syndrom. Ceburtsh. u. Frauenheilk. 56 (1996) 649-653.
10. Heller, C. S., J. P. Elliot: High-order multiple pregnancies complicated by HELLP syndrome. A report of four cases with corticosteroid therapy to prolong gestation. J. Reprod. Med. 42 (1997) 743-746.
11. Heyborne, K. D., M. S. Burke, R. P. Porreco: Prolongation of premature gestation in women with hemolysis, elevated liver enzymes, and low platelets. A report of 5 cases. J. Reprod. Med. 35 (1990) 53-57.
12. Hüskes, K. P., A. Baumgartner, U. Hardt, F. Klink: Doppelseitige, mehrzeitige Spontanruptur der Leber bei HELLP-Syndrom. Chirurg 62 (1991) 221-222.
13. Kändler, C., B. Kevekordes, M. Zenker, M. Kandler, E. Beinder, N. Lang, D. Harms: Prognosis of children born to mothers with HELLP-Syndrome. J. Perinat. Med. (in press).
14. Krick, M., C. Pagel, J. Baltzer: Das zunehmend häufigere HELLP-Syndrom. Diagnostik und Behandlung. Zbl. Gynäkol. 116 (1994) 207-209.
15. Kronthal, A. J., E. K. Fishman, J. E. Kuhlman, M. E. Bohlman: Hepatic infarction in preeclampsia. Radiology 177 (1990) 726-728.
16. Louwen, F., J. Stuessel, A. E. Klezsel, H. P. G. Schneider: Der Einfluß des Geburtsmodus und der fetomaternalen Zirkulation auf den Laborverlauf des HELLP-Syndroms. Arch. Gynecol. Obstet. 258 (Suppl. 1) (1996) 115 (abstract).
17. MacKenna, J., N. L. Dover, R. G. Brame: Preeclampsia associated with hemolysis, elevated liver enzymes, and low platelets - an obstetric emergency? Obstet. Gynecol. 62 (1983) 751-754.
18. Magann, E. F., R. W. Martin, J. D. Isaacs, P. G. Blake: Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP-syndrome. Aust. N. Z. J. Obstet. Gynaecol. 33 (1993) 127-131.
19. Magann, E. F., D. Bass, S. P. Chauhan, D. L. Sullivan, R. W. Martin, J. N. Martin: Antepartum corticosteroids: Disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Amer. J. Obstet. Gynecol. 171 (1994) 1148-1153.
20. Magann, E. F., K. G. Perry, E. F. Meydrech, R. L. Harris, S. P. Chauhan, J. N. Martin: Postpartum corticosteroids: Accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Amer. J. Obstet. Gynecol. 171 (1994) 1154-1158.
21. Magann, E. F., W. E. Roberts, K. G. Perry, S. P. Chauhan, P. G. Blake, J. N. Martin: Factors relevant to mode of preterm delivery with syndrome of HELLP (hemolysis, elevated liver enzymes, and low platelets). Amer. J. Obstet. Gynecol. 170 (1994) 1828-1834.
22. Martin, J. N., P. G. Blake, K. G. Perry, F. McGaul, W. Hess, R. Martin: The natural history of HELLP syndrome: Patterns of disease progression and regression. Amer. J. Obstet. Gynecol. 164 (1991) 1500-1513.
23. Martin, J. N., K. G. Perry, J. F. Miles, P. G. Blake, E. F. Magann, W. E. Roberts, R. W. Martin: The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant and perinatal risk. Brit. J. Obstet. Gynaecol. 100 (1993) 1095-1100.
24. Martin, J. N., K. G. Perry, P. G. Blake, W. A. May, A. Moore, L. Robinette: Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Amer. J. Obstet. Gynecol. 177 (1997) 1011-1017.
25. Neiger, R., S. A. Contag, D. R. Coustan: The resolution of preeclampsia-related thrombocytopenia. Obstet. Gynecol. 162 (1991) 692-695.
26. Neuman, M., R. Ron-El, R. Langer, I. Bukovsky, E. Caspi: Maternal death caused by HELLP syndrome (with hypoglycemia) complicating mild pregnancy-induced hypertension in a twin gestation. Amer. J. Obstet. Gynecol. 162 (1990) 372-373.
27. Rabenbauer, B., P. Schult, T. Fischer, L. Wildt: Hochdosierte Kortikosteroidtherapie beim HELLP-Syndrom. Arch. Gynecol. Obstet. 258 (Suppl. 1) (1996) 114 (abstract).
28. Rath, W., W. Loos, W. Kuhn: Das HELLP-Syndrom. Zbl. Gynäkol. 116 (1994) 195-201.
29. Rath, W.: Aggressives versus konservatives Vorgehen beim HELLP-Syndrom - eine Standortbestimmung. Geburtsh. Frauenheilk. 56 (1996) 265-271.
30. Rath, W., W. Loos, W. Kuhn, H. Graeff: The importance of early laboratory screening methods for maternal and fetal outcome in cases of HELLP-Syndrome. Europ. J. Obstet. Gynecol. 36 (1990) 43-51.
31. Reubinoff, B. E., J. G. Schenker: HELLP-Syndrome - a syndrome of hemolysis, elevated liver enzymes, and low platelet count - complicating preeclampsia-eclampsia. Int. J. Gynecol. Obstet. 36 (1991) 95-102.
32. Saura, P., L. Blanch, E. Capdevila: Spontaneous rupture of the liver during pregnancy. Intensive Care Med. 21 (1995) 95-96.
33. Schwerk, Ch., P. Schmidt-Rhode, M. Zimmermann, R. Hackenberg, H. Prinz: Klinischer und laborchemischer Verlauf des HELLP-Syndroms - eine retrospektive Analyse. Z. Geburtsh. Neonatol. 200 (1996) 109-114.
34. Sibai, B. M., M. M. Taslimi, A. El-Nazer, E. Amon, B. C. Mabie, G. M. Ryan: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Amer. J. Obstet. Gynecol. 155 (1986) 501-509.
35. Sibai, B. M., M. K. Ramadan, I. Usta, M. Salama, B. M. Mercer, S. A. Friedman: Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Amer. J. Obstet. Gynecol. 169 (1993) 1000-1006.
36. Sibai, B. M., B. M. Mercer, E. Schiff, S. A. Friedman: Aggressive versus expectant management of severe preeclampsia at 28 to 32 week's gestation: a randomized controlled trial. Amer. J. Obstet. Gynecol. 171 (1994) 818-822.
37. Sliutz, G., B. Schäfer, R. Obwegeser, E. Joura, A. Hammerle, Ch. Dadak: Geburtshilfliches Management bei Patientinnen mit HELLP-Syndrom. Z. Geburtsh. Perinat. 197 (1993) 112-118.
38. 2 serotonergic receptor antagonist, could be useful in the HELLP syndrome. Hypertension in Pregnancy 12 (1993) 183-190.
39. Spitzer, D., H. Steiner, H. Schaffer, A. Staudach: Gibt es ein intermittierendes HELLP-Syndrom? Z. Geburtsh. Perinat. 197 (1993) 84-86.
40. Thiagarajah, S., J. Bourgeois, G. Harbert, M. Caudle: Thrombozytopenia in preeclampsia: associated abnormalities and management principles. Amer. J. Obstet. Gynecol. 150 (1984) 1-7.
41. Upleger, F., P. Biel: Akutes HELLP-Syndrom mit spontaner Leberruptur sub partu. Z. Geburtsh. Neonatol. 200 (1996) 127-128.
42. Van Dam, P. A., M. M. Renier, M. Baekelandt, P. Buytaert, F. Uyttenbroeck: Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet. Gynecol. 73 (1989) 97-102.
43. van Pampus, M., G. H. Wolf, S. M. Westenberg, J. A. M. van der Post, G. J. Bonsel, P. E. Treffers: Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Europ. J. Obstet. Gynecol. 76 (1998) 31-36.
44. Visser, W., H. C. S. Wallenburg: Temporising management of severe preeclampsia with and without HELLP syndrome. Brit. J. Obstet. Gynecol. 102 (1995) 111-117.
45. Weinstein, L.: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Amer. J. Obstet. Gynecol. 142 (1982) 159-167.
46. Weinstein, L.: Preeclampsia/Eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet. Gynecol. 66 (1985) 657-660.
47. Welsch, H., A. Krone: Mütterliche Mortalität beim HELLP-Syndrom in Bayern 1983-1992.Zbl. Gynäkol. 116 (1994) 202-206.